September 20 - 21, 2019

 

The Bellagio

Las Vegas, NV

 

CME/CE Credit

We are in the process of putting together the 12th Annual (2019) Perspectives in Rheumatic Diseases Conference program. 
Please SIGN UP for email updates to keep informed of program developments for our upcoming conference as they become available.

 

SIGN UP FOR UPDATES

 

THIS CONFERENCE IS FOR YOU

Rheumatologists • Family Physicians • Internists • Physician Assistants • Nurse Practitioners • Nurses • Pharmacists

 
LEARNING OBJECTIVES

After completing this live activity, participants should be better able to:

  • Identify the various cytokine pathways that underlie the process by which rheumatoid arthritis develops and progresses and that serve as potential targets for therapy.
  • Develop effective protocols for conducting laboratory studies and incorporating their results to improve outcomes in patients with rheumatoid arthritis.
  • Discuss current ACR/EULAR guidelines for managing rheumatoid arthritis, including the treat-to-target approach.
  • Design effective treatment strategies for managing rheumatoid arthritis
  • Demonstrate awareness of current guidelines for management of psoriasis.
  • Outline treatment plans for psoriasis that consider the use of new agents, with new mechanisms, and that include strategies for modifying treatment as needed based on results and patient satisfaction.
  • Create a treatment plan for psoriatic arthritis that incorporates tools for assessing the impact of psoriatic arthritis and that anticipates the potential need to switch or augment therapy.
  • Describe the safety and efficacy of available agents for psoriatic arthritis.
  • Clinically distinguish between the various types of axial spondylitis.
  • Outline the current and emerging therapeutic options that target established and newly recognized pathways in the pathogenesis of axial spondyloarthropathies including ankylosing spondylitis.
  • Differentiate among the dermatologic manifestations of rheumatologic conditions and design appropriate treatment strategies for properly selected patients.
  • Identify the potential gastrointestinal complications that commonly emerge in the setting of rheumatologic disease, including those induced by immunological therapies.
  • Design effective multidisciplinary strategies for managing gastrointestinal complications in patients with autoimmune disorders.
  • Integrate imaging options to aid in the diagnosis of gout.
  • Recognize evidence-based recommendations for dosing urate-lowering therapies to optimize efficacy in patients with gout.
  • Establish treatment plans for gout that achieve targeted levels of serum uric acid.
  • Identify diagnostic and therapeutic approaches in the management of inflammatory muscle diseases.
  • Compare and contrast the safety, efficacy, and mechanisms of various agents available for managing pain in the context of autoimmune disorders.
  • Design effective treatment strategies for the various manifestations of localized and systemic scleroderma.
  • Summarize current and emerging research on the mechanisms of the pathology of systemic lupus erythematosus and treatment of lupus nephritis.
  • Review data from clinical trials – including failed trials – on candidate therapies that target various pathways involved in systemic lupus erythematosus.
  • Clinically identify various forms of vasculitis, IgA and granulomatosis with polyangiitis (Wegener's), and institute appropriate therapy in patients of any age.
  • Identify work/life balance strategies for reducing clinician burnout so as to improve satisfaction and continue delivery of effective patient care.

 

CME/CE Accreditation

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville School of Medicine and Global Academy for Medical Education, LLC. The University of Louisville School of Medicine is accredited by the ACCME to provide continuing education for physicians.

The University of Louisville Office of Continuing Medical Education & Professional Development designates this live activity for a maximum of 14.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 
ABIM MOC Points

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 14.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 
AAFP Credit

This Live activity, 11th Perspectives in Rheumatic Diseases presented by Family Practice News, Rheumatology News & Internal Medicine News, with a beginning date of 09/14/18, has been reviewed and is acceptable for up to 13.5 Prescribed credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 
JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 14.0 contact hours (1.4 CEUs) of the Accreditation Council for Pharmacy Education. Type of Activity: Application

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 14.0 contact hours.  Pharmacotherapy contact hours for Advanced Practice Nurses will be designated on your certificate.

Type of Activity
Knowledge

 
FACULTY DISCLOSURE

All individuals who affect the content of the continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made at the time of the activity.

 
SPECIAL NEEDS

We encourage participation by all individuals. If you have a disability, advance notification of any special needs will help us better serve you. Please contact Global Academy for Medical Education at least 3 weeks in advance at 312.965.8006 or t.rillo@globalacademycme.com.

Jointly Provided By

In Association With